Wedge Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wedge Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.5M	Sell	126,539 -33,467	-21%	-$7.33M	0.5%	82
2026 Q1	$30.2M	Sell	160,006 -28,872	-15%	-$5.05M	0.56%	68
2025 Q4	$32.1M	Sell	188,878 -22,307	-11%	-$3.42M	0.58%	68
2025 Q3	$27.8M	Buy	+211,185	New	+$25.3M	0.47%	79
2025 Q2	–	Sell	-239,868	Closed	-$29.8M	–	525
2025 Q1	$29.8M	Sell	239,868 -3,137	-1%	-$409K	0.58%	81
2024 Q4	$29.9M	Sell	243,005 -48,679	-17%	-$5.74M	0.54%	64
2024 Q3	$32.5M	Buy	+291,684	New	+$32M	0.56%	68
2024 Q1	–	Sell	-243,357	Closed	-$29.9M	–	509
2023 Q4	$29.9M	Buy	243,357 +20,587	+9%	+$2.57M	0.53%	66
2023 Q3	$28.8M	Sell	222,770 -16,312	-7%	-$2.17M	0.57%	73
2023 Q2	$29.6M	Sell	239,082 -33,786	-12%	-$4.55M	0.47%	73
2023 Q1	$39.9M	Buy	272,868 +18,379	+7%	+$2.72M	0.67%	23
2022 Q4	$40.5M	Buy	254,489 +12,524	+5%	+$1.84M	0.65%	27
2022 Q3	$32.3M	Buy	241,965 +1,343	+0.6%	+$204K	0.55%	77
2022 Q2	$37.5M	Buy	+240,622	New	+$37M	0.6%	49
2021 Q1	–	Sell	-180,075	Closed	-$29.7M	–	560
2020 Q4	$29.7M	Sell	180,075 -14,950	-8%	-$2.23M	0.34%	92
2020 Q3	$27.8M	Buy	+195,025	New	+$24.2M	0.37%	82
2020 Q1	–	Sell	-288,973	Closed	-$43.1M	–	557
2019 Q4	$43.1M	Buy	288,973 +12,960	+5%	+$1.76M	0.48%	70
2019 Q3	$35.4M	Buy	276,013 +20,553	+8%	+$2.76M	0.41%	82
2019 Q2	$36.4M	Sell	255,460 -30,981	-11%	-$4.16M	0.42%	81
2019 Q1	$40.9M	Buy	+286,441	New	+$37.4M	0.47%	64

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Wedge Capital Management's JAZZ Position: Q2 2026 in Review

Wedge Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 21% in Q2 2026, selling an estimated $7.33M and leaving 126,539 shares worth $30.5M. The position accounts for 0.5% of the portfolio, ranked #82.

Wedge Capital Management first reported a position in JAZZ in Q1 2019 and has held it in 20 quarters since. The position peaked at $43.1M in Q4 2019. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Wedge Capital Management held 126,539 shares of Jazz Pharmaceuticals worth $30.5M as of Q2 2026.
Wedge Capital Management sold 33,467 Jazz Pharmaceuticals shares in Q2 2026, an estimated $7.33M.
Jazz Pharmaceuticals made up 0.5% of Wedge Capital Management's portfolio in Q2 2026, its #82 holding.
Wedge Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 20 quarters since.
Wedge Capital Management's Jazz Pharmaceuticals position peaked at $43.1M in Q4 2019.
69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.